In some patients, structural kidney changes and albuminuria may regress upon successful treatment of the underlying metabolic defect (e.g., by pancreas transplantation in T1DM) (34) or antiproteinuric treatment with RAAS blockers, SGLT2i, or GLP-1 RA (35). This evidence concerns the gene GLP1R and type 1 diabetes mellitus.